23.06.2021Aleta Biotherapeutics and Cancer Research UK collaborate to advance blood cancer therapy into the clinic

Press Release
17.06.2021Aura Biosciences Assembles New Bladder Cancer Focused Scientific Advisory Board

Press Release
08.06.2021Aura Biosciences Appoints Sapna Srivastava, Ph.D., to its Board of Directors

In The News
14.04.2021Highlight Therapeutics to present data from Phase 2 immunotherapy studies of liver metastases and melanoma data at AACR Virtual Annual Meeting 202

Press Release
14.04.2021Aura Biosciences Announces Publication of Data in Cancer Immunology Research Supporting the Immune Mediated Mechanism of Action of the Virus-Like Drug Conjugate (VDC) Technology Platform with Broad Application in Cancer Treatment

Press Release
12.04.2021Francesco Maria Lavino appointed Chief Executive Officer of F2G Ltd

Press Release
01.04.2021 Eloxx Pharmaceuticals Acquires Zikani Therapeutics

Press Release
24.03.2021Aura Biosciences Expands Executive Leadership Team with the Appointment of Mark De Rosch, Ph.D., as Chief Operating Officer

Press Release
22.03.2021Aura Biosciences Announces Oversubscribed $80 Million Financing

Press Release
17.03.2021Advent Life Sciences’ founded Amphista Therapeutics raises $53M in oversubscribed Series B round to advance next generation targeted protein degradation assets

Press Release